Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
1ray's Profile
Displaying 51-61 of 61 result(s).
ROX Castle Brands
12/20/2013 7:59:13 AM
ROX  moving 10/19/13 6.5% from .80
LGBS Legends Business Grp
12/20/2013 7:46:19 AM
LGBS looking for the .002 breakout
LGBS Legends Business Grp
12/19/2013 4:27:24 PM
LGBS......WARNING.....NO PUMP AND D
MG10 MASSIVE GAINS by massivegains10
12/19/2013 2:41:46 PM
LGBS  hope ya watching this one  
LGBS Legends Business Grp
12/19/2013 11:18:00 AM
LGBS.... hit a high of .002 from a
LGBS Legends Business Grp
12/19/2013 10:34:48 AM
LGBS from .0016 to .0018 this mourn
LGBS Legends Business Grp
12/19/2013 8:39:11 AM
WARNING!!!!!!   LGBS......  after
SUPERHEROSTOCKPICKERS
12/19/2013 8:20:07 AM
Welcome Superheroes..... glad I spo
ALERTS, HOT STOCKS & CHARTS
12/10/2013 9:22:48 AM
OTHM another stock setting up to mo
ALERTS, HOT STOCKS & CHARTS
12/10/2013 9:21:17 AM
this has been a dormant stock nearl
RMTG Regenerative Medical Technology Group Inc.
12/10/2013 9:07:44 AM
Time to start getting on board befo
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Recap of the 27th Shanghai International Film Festival Awards
  • Kaanch Network's Bold Steps Towards Transforming DeFi in 2025
  • Wilson Blanchard Management's Successful WB CondoCon Event
  • Martini Market $MRT Presale Hits 40% Milestone Within a Day
  • Lawsuit Filed by Attorneys Against Universal Health Services
  • Vaultro Finance Sees Surge in $VLT Presale on XRP Ledger
  • Long Read Sequencing Market Anticipated to Surge to Nearly $7 Billion
  • Discover How QuidMiner Revolutionizes Cloud Mining Today
  • AIXA Miner Launches Innovative Free Cloud Mining Platform
  • Perspective Therapeutics Advances Clinical Trial for Cancer Treatment
  • Significant Efficacy of Vyepti in Treating Severe Migraines
  • Eptinezumab's Impact on Severe Migraines: New Insights
  • MetaVia Unveils Promising DA-1241 Data for Liver Health
  • Eli Lilly's Orforglipron Shows Promise for Type 2 Diabetes
  • Eptinezumab's Trial Results: A Breakthrough in Migraine Treatment
  • Investors Can Step Forward in Vestis Corporation Legal Challenge
  • New Insights on Eptinezumab's Effectiveness for Chronic Migraines
  • Perspective Therapeutics Showcases Innovations in Cancer Treatment
  • Shokz Introduces 5 Pro Athletes for Upcoming Endurance Run
  • Bitcoin Solaris Prepares for Exciting Public Launch Next Month
  • William Stern's Cardiff Transforms Working Capital Solutions
  • MolecuLight Unveils Multimodal Imaging Innovations for Wound Care
  • Innovative Diabetes Treatments Unveiled by Gan & Lee Pharmaceuticals
  • AIXA Miner: Revolutionizing Passive Income in Crypto Space
  • Teamsters Nurses Gear Up for Rally Ahead of Negotiations
  • Class Action Lawsuit Opportunity for Compass Diversified Holdings Investors
  • High Arctic Energy Services Reports Successful Annual Meeting
  • Key Updates on Reckitt Benckiser Securities Class Action
  • Understanding the Red Cat Holdings Class Action Lawsuit
  • Legal Update: Compass Diversified Shareholder Lawsuit News
  • Investor Alert: Key Information for Organon Shareholders
  • Investors in Tempus AI - Know Your Rights and Options
  • The China Fund, Inc. Moves Forward with Liquidation Plan
  • DDB Worldwide Achieves Unmatched Recognition at Cannes Lions
  • CHAI Transforms AI Performance with Innovative 4-Bit Model
  • Join the Movement: Apple Class Action Lawsuit Opportunities
  • Enzon and Viskase Announce Exciting Merger Agreement Plans
  • Jane Silverstone Segal's Significant Share Acquisition in DAVIDsTEA
  • enCore Energy Sells Shares to Strengthen Market Position
  • Revolutionize Your Finances with the New XRP Mining App
  • Novo Nordisk Reveals Exciting Amycretin Data at ADA 2025
  • Novo Nordisk's Wegovy Trial Success: Weight Loss Breakthrough
  • Innovative Stem Cell Therapies Offer Hope for Diabetes Care
  • Breakthrough Study: Abbott's Program Enhances Diabetes Care
  • Novo Nordisk's amycretin Moves to Phase 3 for Weight Management
  • Medtronic's MiniMed 780G System Shows Significant Diabetes Benefits
  • Water vs Diet Drinks: A Breakthrough in Diabetes Remission
  • Automated Insulin Delivery Enhances Pregnancy Outcomes for Diabetics
  • Innovative AI Models Transform Type 1 Diabetes Detection
  • Breakthrough Medical Device Addresses Lipohypertrophy in Diabetes
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site